Participant flow

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT · Source last updated 2020-08-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.

   id

   FG000

   title

   ALT-803, IV, 1 mcg/kg

2. description

   Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.

   id

   FG001

   title

   ALT-803, IV, 3 mcg/kg

3. description

   Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.

   id

   FG002

   title

   ALT-803, IV, 6 mcg/kg

4. description

   Weekly dose of ALT-803 at assigned dose once a week for 4 weeks.

   id

   FG003

   title

   ALT-803, IV, 10 mcg/kg

5. description

   Weekly dose of ALT-803 at assigned dose subcutaneously, once a week for 4 weeks.

   id

   FG004

   title

   ALT-803, SQ, 6 mcg/kg

6. description

   Weekly dose of ALT-803 at assigned dose , subcutaneously, once a week for 4 weeks.

   id

   FG005

   title

   ALT-803, SQ, 10 mcg/kg

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         3

      3. group Id

         FG002

         num Subjects

         4

      4. group Id

         FG003

         num Subjects

         3

      5. group Id

         FG004

         num Subjects

         8

      6. group Id

         FG005

         num Subjects

         9

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         3

      3. group Id

         FG002

         num Subjects

         4

      4. group Id

         FG003

         num Subjects

         3

      5. group Id

         FG004

         num Subjects

         8

      6. group Id

         FG005

         num Subjects

         9

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      5. group Id

         FG004

         num Subjects

         0

      6. group Id

         FG005

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice